Levi & Korsinsky announces the commencement of a class action lawsuit in the USDC for the District of New Jersey on behalf of shareholders of Perrigo Company plc (NYSE: PRGO) who purchased shares between between April 21, 2015 and May 11, 2016. This action is also brought on behalf of all investors in Perrigo common stock as of November 13, 2015, the deadline for Perrigo investors to tender their shares in connection with a tender offer made by Mylan N.V.
The complaint alleges that Perrigo made false and/or misleading statements about its financial condition and growth prospects in an effort to convince shareholders to reject a merger proposal by Mylan N.V. On April 8, 2015, Mylan N.V. offered to purchase Perrigo for $205 per share. Then on April 21, 2015, Perrigo rejected the offer and told investors that the offer undervalued Perrigo. Then on November 13, 2015, a majority of Perrigo’s shareholders declined to tender their shares, thus defeating Mylar’s tender offer. Since the defeat of this offer, Perrigo’s CEO has resigned, it has lowered its 2016 earnings guidance, and incurred a $185 million impairment charge related to its acquisition of Omega Pharma NV.
If you suffered a loss in Perrigo you have until July 18, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
To receive more information, please fill out the form.